NorthWest Biotherapeutics Inc (NWBO)

[Nemesis18]

The reason I ask what the differentiation is between DCVAX-l and other piggy back Dendritic Cell Treatment approaches , which seem to be gathering real ground & traction, in-terms of results lately in 2024, is that some shareholders here seem to be believe that those successes, in some way, validates the efficacy of DCVAX-L.
Which it doesn’t ?
Just because I own a blue jacket, doesn’t mean that I have a share in the sale of other better blue jackets in the future, that have extra zips, pockets & a hood !

Basically, when do the small investors realistically hope to get a return, as there is not enough income to satisfy the spread ?
Over the years, NWBO’s iteration has been left behind, because they did not have the established research infrastructure to continually tweak and improve their iteration.

You can dilute shares only for so long, but there comes the time that you have to pay the piper, to balance the books.